Camerer E, Rottingen J A, Iversen J G, Prydz H
Biotechnology Centre of Oslo, N-0371 Oslo, Norway.
J Biol Chem. 1996 Nov 15;271(46):29034-42. doi: 10.1074/jbc.271.46.29034.
We have recently reported that the activated serine protease and blood coagulation Factor VII (FVIIa) can induce Ca2+ oscillations in Madin-Darby canine kidney cells. We now demonstrate a similar response by Madin-Darby canine kidney cells to the active coagulation Factor X (FXa), which is also a serine protease and a substrate of the tissue factor (TF).FVIIa complex in the initiation of the coagulation cascade. The phosphatidyl inositol-specific phospholipase C inhibitor U73122 inhibited the signals elicited by both FVIIa and FXa. Lack of sensibility to the tyrosine kinase inhibitors herbimycin A, genistein, and the tyrphostin AG18 and discordance between TF expression and FVIIa responsiveness argued against TF acting as a cytokine-like receptor, with tyrosine kinase-mediated activation by FVIIa. As demonstrated using the protease inhibitor benzamidine and by specific active site inhibition with 1,5-dansyl-Glu-Gly-Arg chloromethyl ketone, both FVIIa and FXa lost their ability to elicit a calcium response when devoid of their proteolytic activity. Consistent with this, the native (zymogen) form of Factor X did not induce Ca2+ transients. Homologous but not heterologous inhibition of FVIIa- and FXa-evoked Ca2+ signals by 1,5-dansyl-Glu-Gly-Arg chloromethyl ketone-inactivated FVIIa and FXa suggested that each factor had its own specific cell surface anchoring receptor. The two coagulation factors did not show homologous desensitization as seen for thrombin stimulation. Studies with hirudin excluded involvement of the established activation pathway through thrombin itself. Lack of desensitization of the response to FVIIa or FXa by thrombin ruled out any involvement of proteinase activated receptor-1 (PAR-1), the thrombin receptor. We speculate that FXa and FVIIa may work via a receptor (possibly common) analogous to PAR-1 or its functional homologue PAR-2. Although TF is essential for the FVIIa-induced signaling event, its role in the phosphatidyl inositol-specific phospholipase C-mediated Ca2+ signal may be in anchoring FVIIa to the cell surface rather than in transmembrane signal mediation.
我们最近报道,活化的丝氨酸蛋白酶及凝血因子VII(FVIIa)可在犬肾细胞(Madin-Darby canine kidney cells,简称MKC细胞)中诱导钙离子振荡。现在我们证明,MKC细胞对活性凝血因子X(FXa)也有类似反应,FXa同样是一种丝氨酸蛋白酶,也是组织因子(TF) - FVIIa复合物在凝血级联反应起始过程中的底物。磷脂酰肌醇特异性磷脂酶C抑制剂U73122可抑制FVIIa和FXa引发的信号。对酪氨酸激酶抑制剂赫曲霉素A、染料木黄酮及 tyrphostin AG18不敏感,以及TF表达与FVIIa反应性之间的不一致,表明TF并非作为类细胞因子受体发挥作用,即FVIIa不会通过酪氨酸激酶介导其激活。正如使用蛋白酶抑制剂苯甲脒以及用1,5 - 丹磺酰 - 谷氨酸 - 甘氨酸 - 精氨酸氯甲基酮进行特异性活性位点抑制所证明的那样,当FVIIa和FXa失去蛋白水解活性时,它们都失去了引发钙反应的能力。与此一致的是,因子X的天然(酶原)形式不会诱导钙离子瞬变。1,5 - 丹磺酰 - 谷氨酸 - 甘氨酸 - 精氨酸氯甲基酮使FVIIa和FXa失活后,对FVIIa和FXa引发的钙离子信号产生同源而非异源抑制,这表明每个因子都有其自身特定的细胞表面锚定受体。这两种凝血因子并未表现出像凝血酶刺激时那样的同源脱敏现象。水蛭素研究排除了通过凝血酶自身既定激活途径的参与。凝血酶对FVIIa或FXa反应无脱敏作用,排除了蛋白酶激活受体 - 1(PAR - 1,凝血酶受体)的任何参与。我们推测,FXa和FVIIa可能通过一种类似于PAR - 1或其功能同源物PAR - 2的受体(可能是共同的)发挥作用。虽然TF对于FVIIa诱导的信号事件至关重要,但其在磷脂酰肌醇特异性磷脂酶C介导的钙离子信号中的作用可能是将FVIIa锚定在细胞表面,而非跨膜信号介导。